v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities:    
Net loss $ (10,537,000) $ (7,388,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of fixed assets 286,000 194,000
Foreign exchange loss
Non-cash payment for asset acquisition 1,991,000
Amortization of intangible assets 33,000 34,000
Amortization of right of use asset 273,000 231,000
Share-based compensation 1,829,000 2,399,000
Change in fair value of derivative (4,912,000)
Loss on disposition of assets 769,000
Changes in operating assets and liabilities:    
Accounts receivable (662,000) (1,016,000)
Contract assets 321,000 533,000
Inventory (1,837,000) (643,000)
Right-of-use asset (66,000)
Other assets 797,000 (493,000)
Accounts payable 2,360,000 715,000
Earnout payable (100,000) (50,000)
Accrued expenses 376,000 22,000
Right-of-use liabilities (289,000) (212,000)
Contract liabilities (938,000) 135,000
Net cash used in operating activities (10,240,000) (5,605,000)
Cash flows from investing activities:    
Purchases of property and equipment (124,000) (1,453,000)
Net cash used in investing activities (124,000) (1,453,000)
Cash flows from financing activities:    
Proceeds from convertible notes 9,866,000
Repayment of convertible notes (2,356,000)  
Proceeds from issuance of common stock – Capital Raise - Warrants, net of issuance costs 9,952,000
Proceeds from issuance of common stock - At The Market offering, net of issuance costs 1,405,000 337,000
Net cash provided by financing activities 9,001,000 10,203,000
Net increase in cash, cash equivalents and restricted cash (1,363,000) 3,145,000
Cash, cash equivalents and restricted cash, beginning of period 8,873,000 6,869,000
Cash, cash equivalents and restricted cash, end of period 7,510,000 10,014,000
Supplemental disclosure of noncash investing and financing activities:    
Common stock issued related to conversion of convertible debt $ 2,060,000